Drug intake and the dexamethasone suppression test.

Area of Science:

• Clinical chemistry
• Psychiatric diagnostics
• Pharmacology

Background:

• The dexamethasone suppression test (DST) is a diagnostic tool for depression.
• Patient drug use can potentially affect DST outcomes.
• Understanding these interactions is crucial for accurate diagnosis.

Purpose of the Study:

• To evaluate the impact of concomitant drug use on the clinical utility of the DST in psychiatric inpatients.
• To identify specific medications that may cause false-positive or false-negative DST results.
• To discuss the practical limitations imposed by drug interactions on DST as a biomarker for affective disorders.

Main Methods:

• A retrospective chart review was conducted.
• Drug histories were collected from 336 psychiatric inpatients.
• Analysis focused on medications known to affect the hypothalamic-pituitary-adrenal (HPA) axis or drug metabolism.

Main Results:

• A significant proportion of patients (60%) were taking medications that could alter DST results.
• These medications were identified as potential sources of false-positive or false-negative DST findings.
• The prevalence of interfering drug use highlights a major challenge in DST interpretation.

Conclusions:

• The widespread use of interacting medications in psychiatric inpatients poses a significant limitation to the DST's diagnostic accuracy.
• The DST's reliability as a biologic marker for affective syndromes is compromised by patient polypharmacy.
• Clinical interpretation of DST results must carefully consider the patient's current medication regimen.